AMIGO2 accelerates tumor progression by inducing a cancer stem cell-like phenotype

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Amphoterin-induced gene and open reading frame 2 (AMIGO2) is a known driver of liver metastasis.
• AMIGO2 expression correlates with prognosis in cancer patients, particularly those with low spontaneous liver metastasis rates.

Purpose of the Study:

• To investigate the role of AMIGO2 in the development of cancer stem cell-like properties.
• To determine if AMIGO2 influences cancer cell proliferation, sphere formation, and drug resistance.

Main Methods:

• Utilized human gastric (MKN45) and colon (DLD-1) cancer cell lines.
• Employed short hairpin RNA (shRNA) to knockdown AMIGO2 expression.
• Assessed cell proliferation, multicellular sphere formation, drug sensitivity, and in vivo tumor growth in NOD/SCID mice.

Main Results:

• AMIGO2 knockdown suppressed cell proliferation under starvation conditions and reduced sphere formation in 3D culture.
• AMIGO2 silencing decreased half-maximal inhibitory concentrations of anticancer drugs in sphere-forming cells.
• Silencing AMIGO2 inhibited tumor formation and growth in mice, with correlated expression of AMIGO2 and cancer stem cell markers (CD44, CD133, EpCAM).

Conclusions:

• AMIGO2 promotes malignant progression in human cancer cells by inducing a cancer stem cell-like phenotype.
• AMIGO2 is a potential therapeutic target for overcoming drug resistance and improving cancer treatment outcomes.